MedTrace Logo

The Effects of Mandala Coloring on Women During Menopause

NCT07332065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-05-11

No results posted yet for this study

Summary

The aim of this clinical study is to determine the effect of mandala coloring on menopausal symptoms, sexual quality of life, and self-esteem in women during menopause period. The main questions the study aims to answer are as follows:

1. Does mandala coloring reduce the severity of menopausal symptoms in women?
2. Is there an increase in self-esteem levels among women who participate in mandala coloring after the intervention?
3. Is there an increase in the quality of sexual life among women who participate in mandala coloring after the intervention? Researchers will compare the intervention group (those who participated in mandala coloring) with the control group (those who did not participate in any intervention) to evaluate the effectiveness of mandala coloring.

Participants

* Participants in the intervention group will attend 30-minute mandala coloring sessions once a week for 4 weeks.
* Participants in the control group will not receive any intervention during the same period.
* Both groups will be assessed using a questionnaire at the beginning of the study and at the end of the 4th week (pre-test/post-test).

Conditions

  • Menopause
  • Self Esteem
  • Sexual Activity
  • Women
  • Menopause Symptoms

Interventions

OTHER

Mandala coloring

Mandala coloring is a structured creative art activity based on colouring mandala shapes, which consist of circular and symmetrical patterns, increasing focus and promoting relaxation. As one of the art therapies, mandala colouring can have a therapeutic effect on individuals.

Sponsors & Collaborators

  • Kahramanmaras Sutcu Imam University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-25
Primary Completion
2026-02-25
Completion
2026-03-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07332065 on ClinicalTrials.gov